Atenolol
- Generic Name
- Atenolol
- Brand Names
- Tenoretic, Tenormin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H22N2O3
- CAS Number
- 29122-68-7
- Unique Ingredient Identifier
- 50VV3VW0TI
- Background
Atenolol is a cardioselective beta-blocker used in a variety of cardiovascular conditions.
...
- Indication
Indicated for:
1) Management of hypertension alone and in combination with other antihypertensives.
2) Management of angina pectoris associated with coronary atherosclerosis.
3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg.
...
- Associated Conditions
- Alcohol Withdrawal Syndrome, Angina Pectoris, Atrial Fibrillation, Heart Failure, Hypertension, Migraine, Myocardial Infarction, Refractory Hypertension, Secondary prevention Myocardial infarction, Supra-ventricular Tachyarrhythmias, Thyrotoxicosis, Ventricular Tachyarrhythmias
- Associated Therapies
- -
Olmesartan Medoxomil in Atherosclerosis
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-12-14
- Lead Sponsor
- Sankyo Pharma Gmbh
- Target Recruit Count
- 165
- Registration Number
- NCT00185185
VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Novartis
- Target Recruit Count
- 64
- Registration Number
- NCT00171132
- Locations
- 🇨🇭
Novartis Pharmaceuticals, Basel, Switzerland
A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2005-09-12
- Lead Sponsor
- Mylan Bertek Pharmaceuticals
- Target Recruit Count
- 260
- Registration Number
- NCT00158093
- Locations
- 🇺🇸
SFBC International, Inc., Miami, Florida, United States
The Effect of Nebivolol on Insulin Sensitivity
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 54
- Registration Number
- NCT00125853
- Locations
- 🇬🇧
Imperial College London, Paddington, London, United Kingdom
The CLEVER Study - Coreg And Left Ventricular Mass Regression
- Conditions
- Interventions
- First Posted Date
- 2005-04-14
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 287
- Registration Number
- NCT00108082
- Locations
- 🇺🇸
GSK Investigational Site, Milwaukee, Wisconsin, United States
Systolic Hypertension in the Elderly Program (SHEP)
- Conditions
Trial of Antihypertensive Intervention Management
- Conditions
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
- Conditions
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.